Sanofi gets first OK for isatuximab for myeloma, challenging...

J&J gets okay for a third first-line Darzalex combo in US

NICE backs interim funding for J&J/Takeda myeloma regimen

A three-drug regimen for multiple myeloma based on Johnson & Johnson’s Darzalex, Takeda’s Velcade and dexamethasone will be made available to patients in England, but only via the Cance

Myeloma UK launches stratified medicine trial of Darzalex co...

Research-based charities are taking on an ever-growing role in frontline clinical research, and Myeloma UK has just launched a ‘stratified medicine’ trial aimed at helping high risk patient

New Breakthrough status for Darzalex in earlier myeloma trea...

Janssen's drug looking to gain bigger share in crowded myeloma market

Janssen's Darzalex approved for myeloma in Europe

Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.